Publications by authors named "Donald C Manning"

Claim this Profile
I
Intrathecal administration of AYX2 DNA-decoy produces a long-term pain treatment in rat models of chronic pain by inhibiting the KLF6, KLF9 and KLF15 transcription factors.
Julien Mamet, Michael Klukinov, Scott Harris, Donald C Manning, Simon Xie

Mol Pain· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Highlight: Formulation and Toxicology Evaluation of the Intrathecal AYX1 DNA-Decoy in Sprague Dawley Rats.
Julien Mamet, David C Yeomans, Tony L Yaksh, Donald C Manning, Scott Harris

Toxicol Sci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase.
Donald C Manning, Joseph Gimbel, Robert Wertz, Richard Rauck, Alyse Cooper

Pain Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology, pharmacokinetics, and metabolism of the DNA-decoy AYX1 for the prevention of acute and chronic post-surgical pain.
Julien Mamet, Scott Harris, Michael Klukinov, David C Yeomans, Renee R Donahue, Donald C Manning

Mol Pain· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide for complex regional pain syndrome type 1: lack of efficacy in a phase II randomized study.
Donald C Manning, Guillermo Alexander, Joseph C Arezzo, Alyse Cooper, R Norman Harden

J Pain· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single intrathecal administration of the transcription factor decoy AYX1 prevents acute and chronic pain after incisional, inflammatory, or neuropathic injury.
Julien Mamet, Michael Klukinov, Tony L Yaksh, Shelle A Malkmus, Samantha Williams, Donald C Manning

Pain· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "A new definition of neuropathic pain".
Anne Louise Oaklander, Peter R Wilson, Peter A Moskovitz, Donald C Manning, Timothy Lubenow

Pain· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.
Andrea M Barsevick, Charles S Cleeland, Donald C Manning, Ann M O'Mara, Bryce B Reeve

J Pain Symptom Manage· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Sarah Peirce-Sandner, Ralf Baron, Nicholas Bellamy, Donald C Manning

Pain· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.
Dennis C Turk, Robert H Dworkin, Michael P McDermott, Nicholas Bellamy, Laurie B Burke, Donald C Manning

Pain· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, Kathleen W Wyrwich, Dorcas Beaton, Charles S Cleeland, Donald C Manning

J Pain· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questions of balance in chronic pain.
Donald C Manning

Pain· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.
Dennis C Turk, Robert H Dworkin, Laurie B Burke, Richard Gershon, Margaret Rothman, Donald C Manning

Pain· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.
Robert H Dworkin, Dennis C Turk, John T Farrar, Jennifer A Haythornthwaite, Mark P Jensen, Donald C Manning

Pain· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New and emerging pharmacological targets for neuropathic pain.
Donald C Manning

Curr Pain Headache Rep· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.
Dennis C Turk, Robert H Dworkin, Robert R Allen, Nicholas Bellamy, Nancy Brandenburg, Donald C Manning

Pain· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis